Olaine, 2016-05-16 15:41 CEST (GLOBE NEWSWIRE) --
| April 2016, consolidated sales | Sales, thsnd. EUR | Changes to April, 2015 | Share in total sales |
| Russia | 2 969 | -15% | 34% |
| Latvia | 2 160 | 7% | 24% |
| Ukraine | 1 285 | 31% | 15% |
| Belarus | 669 | -9% | 8% |
| Uzbekistan | 426 | 191% | 5% |
| Italy | 284 | 388% | 3% |
| Turkmenistan | 172 | 77% | 2% |
| Kazakhstan | 98 | -51% | 1% |
| Lithuania | 88 | 69% | 1% |
| Kyrgyzstan | 78 | -39% | 1% |
| Other | 593 | -51% | 7% |
| Total | 8 823 | -4% | 100% |
Sales of chain of pharmacies of SIA Latvijas aptieka, fully owned by AS Olainfarm was 1.58 million euros, which represents an increase by 13% compared to April of 2015. Sixty-one pharmacies were operating during this period. Sales of SIA Silvanols during April were .39 million euros, which represents an increase by 18% compared to April of last year. During April of this year, SIA Silvanols sold its products in six European countries, and, with a help of AS Olainfarm, also to Albania, Kosovo and Azerbaijan.
In four months of 2016, according to preliminary consolidated results, consolidated sales of AS Olainfarm were 35.05 million euros, which represents a reduction by 5% compared to the same period of 2015. The biggest sales increase was achieved in Italy, where sales grew by 328%. Sales to Uzbekistan grew by 158%, sales to Turkmenistan grew by 133% while sales to Belarus grew by 51%. Major sales markets in four months of 2016 were Russia, Latvia, Ukraine and Belarus.
| 4 months of 2016, consolidated sales | Sales, thsnd. EUR | Changes to 4 months of 2015 | Share in total sales |
| Russia | 9 274 | -32% | 26% |
| Latvia | 8 780 | 11% | 25% |
| Ukraine | 6 274 | 44% | 18% |
| Belarus | 3 696 | 51% | 11% |
| UK | 939 | 12% | 3% |
| Uzbekistan | 904 | 158% | 3% |
| Kazakhstan | 667 | -24% | 2% |
| Turkmenistan | 654 | 133% | 2% |
| Italy | 530 | 328% | 2% |
| The Netherlands | 473 | -83% | 1% |
| Other | 2 856 | -9% | 8% |
| Total | 35 047 | -5% | 100% |
During 4 months of 2016, sales of pharmacy chain of SIA Latvijas Aptieka was 6.6 million euros, which represents an increase by 18% compared to the same period of 2015. Sales of SIA Silvanols during this 4 months period was 1.6 million euros, which represents an increase by 14% compared to 2015, when its sales during four months were 1.4 million euros. Products of SIA Silvanols were sold to nine European countries and with the help from AS Olainfarm to Albania, Kosovo, Azerbaijan and Belarus.
According to unconsolidated preliminary results, sales of AS Olainfarm during April 2016 reached 7.67 million euros, which represents a reduction by 5% compared to the same period of last year. The biggest sales increase was achieved in Italy, where sales increased by 388%. Sales to Uzbekistan increased by 191%, but sales to Turkmenistan increased by 77%. The major sales markets were Russia, Ukraine, Latvia, Belarus and Uzbekistan. During April 2016, AS Olainfarm sold its products to 27 countries in three continents.
| April 2016, unconsolidated sales | Sales, thsnd. EUR | Changes to April, 2015 | Share in total sales | |
| Russia | 2 969 | -15% | 39% | |
| Ukraine | 1 285 | 31% | 17% | |
| Latvia | 1 103 | 2% | 14% | |
| Belarus | 669 | -9% | 9% | |
| Uzbekistan | 426 | 191% | 6% | |
| Italy | 284 | 388% | 4% | |
| Turkmenistan | 172 | 77% | 2% | |
| Kazakhstan | 98 | -51% | 1% | |
| Kyrgyzstan | 78 | -39% | 1% | |
| Moldova | 72 | 31% | 1% | |
| Other | 508 | -51% | 7% | |
| Total | 7 665 | -5% | 100% |
According to unconsolidated preliminary results sales of AS Olainfarm in four months of 2016 were 30.39 million euros, which represents a reduction by 7% compared to the same period of 2015. The biggest sales increase was achieved in Italy, where sales grew by 328%. Sales to Uzbekistan grew by 158%; sales to Turkmenistan grew by 133%, while sales to Belarus grew by 51%. Major sales markets of AS Olainfarm in four months of 2016 were Russia, Ukraine, Latvia and Belarus. In total, during four months of 2016 products of AS Olainfarm were sold to 37 countries in three continents.
| 4 months of 2016, unconsolidated sales | Sales, thsnd. EUR | Changes to 4 months of 2015 | Share in total sales |
| Russia | 9 274 | -32% | 31% |
| Ukraine | 6 190 | 42% | 20% |
| Latvia | 4 650 | 9% | 15% |
| Belarus | 3 696 | 51% | 12% |
| UK | 939 | 12% | 3% |
| Uzbekistan | 904 | 158% | 3% |
| Kazakhstan | 667 | -24% | 2% |
| Turkmenistan | 654 | 133% | 2% |
| Italy | 530 | 328% | 2% |
| The Netherlands | 473 | -83% | 2% |
| Other | 241 | -6% | 8% |
| Total | 30 387 | -7% | 100% |
According to preliminary estimates of AS Olainfarm, unconsolidated sales of company in 2016 could reach 90 million euros, while consolidated sales are expected to reach 103 million euros. According to preliminary sales figures published here, in four months of 2016, the Company has attained 34% of its target for unconsolidated sales and 34% of its target for consolidated sales.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv